'The healthcare imaging software provider’s shares have come under pressure since the release of a broker note out of UBS on Tuesday. It downgraded its shares to a neutral rating with a $29.65 price target. While the broker likes Pro Medicus and was pleased with its latest contract win, it isn’t a fan of its current valuation.'
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$318.70 |
Change
4.020(1.28%) |
Mkt cap ! $33.36B | |||
| Open | High | Low | Value | Volume |
| $319.39 | $325.00 | $316.78 | $53.64M | 167.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 31 | $318.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $318.73 | 15 | 3 |
View Market Depth
| Last trade - 15.34pm 10/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |